What is the main business of Polifarm?

The main business activity of Polifarm focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on August 5, 2003.

Where is the headquarters located?

The headquarters is located at: Al.Spółdzielczości Pracy 78, 20-147 Lublin.

Who is on the management board?

The management board includes: Bożena Szymańska (President of the Management Board) and Katarzyna Ewa Nockowska Stańczak (Vice President of the Management Board).

What is the share capital?

The share capital of the company is PLN 12,250,000 (approx. $3.3 million).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

The company reported a revenue of $25,298,823 in 2024, which is an increase of 11.1% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $363,482, meaning the company increased its profit by 78.3%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $19,428,569 in 2024, representing 79% of all operating expenses.

Polifarmsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2003-08-05

Share capital

12 250 000,00 PLN

Registered address

Al.spółdzielczości Pracy 78, 20-147 Lublin, Poland

Electronic delivery address

AE:PL-34026-61418-BHWES-27

Financials

Revenue history (in m)

Financial insight

Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 28.88mMedianUSD 1.75mAverageUSD 5.00m

Net profit

This companyUSD 805.41kMedianUSD 17.49kAverageUSD 85.24k

Operating costs

This companyUSD 27.81mMedianUSD 1.72mAverageUSD 4.85m

Assets

This companyUSD 9.32mMedianUSD 495.38kAverageUSD 1.71m

Industry

Bank accounts

Registered as a VAT taxpayer on 2004-09-06. Active

ING Bank Śląski
02 1050 0086 1000 0023 4093 9483
ING Bank Śląski
47 1050 0086 1000 0023 0527 1773
ING Bank Śląski
72 1050 0086 1000 0090 8117 7223

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

Type	Amount
Buildings and premises	PLN 12,032PLN 12,032

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Public sector contracts

Polifarm is the contractor in one public sector contract, worth PLN 17.96.

Signed	Subject	Public buyer	Value
Aug 4, 2026	Zakup materiałów do uzupełnienia apteczki ratowników na plaży przy ul ,Kajski (inactive)	Iławskie Centrum Sportu, Turystyki I Rekreacji	PLN 17.96

Public buyer	Value
Iławskie Centrum Sportu, Turystyki I Rekreacji	PLN 17.96

National Health Fund (NFZ) contracts

Polifarm has been an NFZ healthcare provider since 2019. In 2026 it is performing 7 contracts with a total value of USD 405.19. All its contracts were worth USD 1.76k in total.

NFZ contract value by year (USD)

Type of care	NFZ branch	Contracts	Value in 2026
Programy pilotażowe	podkarpackie	1	USD 324.15
Programy pilotażowe	wielkopolskie	1	USD 81.04
Inne usługi realizowane w aptekach	lubelskie	1	USD 0.00
Inne usługi realizowane w aptekach	łódzkie	1	USD 0.00
Inne usługi realizowane w aptekach	podlaskie	1	USD 0.00

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Aleksandra Olszacka – Vice President of the Management Board

Bożena Szymańska – President of the Management Board

Katarzyna Nockowska Stańczak – Vice President of the Management Board

Manner of representation

In the event of the appointment of a multi-member management board – joint action of two members of the management board or of a member of the management board jointly with a commercial proxy. The commercial proxy makes declarations of will on behalf of the company jointly with a member of the management board or, if joint commercial proxy has been granted, with another commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Doz S.A.	24,500	$3,309,022.15	100%

Beneficial owners

Person	Rights

Subsidiaries

Name	Share value	Stake
Izmarsp. z o.o.	2,602,106.97 USD	76.006%
Galen 2002sp. z o.o.	1,313,884.39 USD	76%
Avena Sativasp. z o.o.	790,788.76 USD	75.9995%

Competitors

Name	Revenue	Website
DR ZdrowieS.A.	$40,415,498.47	drzdrowie.pl
Dolnośląska Grupa AptecznaS.A.	$30,168,188.68	dgasa.pl
Farmacja SpołecznaS.A.	$28,931,457.55	farmacjaspoleczna.ap.info.pl
Cefarm RzeszówS.A.	$28,356,418.72	cefarmrzeszow.pl
Management CompanyS.A.	$18,905,980.22	managementcompany.pl
Przedsiębiorstwo Produkcyjno-Handlowe Apimexsp. z o.o.	$16,601,428.28	apimex.pl
APIS Farmacjasp. z o.o.	$14,614,704.02	apisapteka.pl
Farmjugsp. z o.o.	$14,506,326.49	farmjug.pl
Fragalsp. z o.o.	$5,374,285.81	aptekafragal.pl
Modrzewscysp. j.	$5,602,358.99	aptekacentrum.lublin.pl

Change history

Date	Event
2015-06-30	PKD change (Removed: 10.86.Z, 10.89.Z, 21.10.Z, 49.41.Z, 63.11.Z, 63.12.Z, 64.20.Z, 68.10.Z, 68.20.Z, 70.10.Z, 70.22.Z, 73.20.Z, 77.11.Z, 77.12.Z, 77.33.Z, 77.39.Z, 78.10.Z, 78.30.Z, 82.30.Z, 82.99.Z, 85.59.B)
2010-02-18	Address change (Syrokomli 5b, 03-335, Warszawa → Al.spółdzielczości Pracy 78, 20-147, Lublin)
2010-02-18	PKD change (Removed: 15.88.Z, 15.89.Z, 24.41.Z, 24.42.Z, 24.51.Z, 24.52.Z, 36.63.Z, 50.10.B, 51.18.Z, 51.36.Z, 51.37.Z, 51.44.Z, 51.45.Z, 51.46.Z, 51.47.Z, 51.55.Z, 51.85.Z, 51.90.Z, 52.31.Z, 52.32.Z, 52.33.Z, 52.48.A, 60.24.A, 60.24.B, 63.11.C, 63.12.C, 63.21.Z, 63.40, 65.21.Z, 65.22.Z, 65.23.Z, 67.13.Z, 70.20.Z, 71.10.Z, 71.21.Z, 71.33.Z, 71.34.Z, 72.10.Z, 72.2, 72.30.Z, 72.40.Z, 74.13.Z, 74.14.A, 74.40.Z, 74.87.B, 80.42.B, 90.03.Z, 93.05.Z; Added: 10.86.Z, 10.89.Z, 21.10.Z, 21.20.Z, 47.19.Z, 47.29.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.91.Z, 49.41.Z, 52.10.B, 63.11.Z, 63.12.Z, 64.20.Z, 64.99.Z, 68.10.Z, 68.20.Z, 70.10.Z, 70.22.Z, 73.20.Z, 77.11.Z, 77.12.Z, 77.33.Z, 77.39.Z, 78.10.Z, 78.30.Z, 82.30.Z, 82.99.Z, 85.59.B, 86.90.E)
2006-09-05	Share capital change (50,000.00 PLN → 12,250,000.00 PLN)
2004-12-23	Address change (Al. Wojska Polskiego 2, 01-524, Warszawa → Syrokomli 5b, 03-335, Warszawa)

FAQ

Last updated: 2026-10-07